Experienced healthcare and rehabilitation technology professional brings more than 30 years of experience in commercialization and new business developmentr all eligible Medicare[...]
Finalized Medicare reimbursement pathway for personal exoskeletons expands access for all eligible Medicare beneficiaries MARLBOROUGH, MA, and YOKNEAM ILLIT, Israel, April 12, 2024[...]
Bicameral legislation seeks to codify annual examinations and assessments for assistive technologies, including Personal Exoskeletons, for Veterans with Spinal Cord Injury MARLBOROUGH,[...]
Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched[...]
Lifeward brand reflects the Company’s commitment to pioneering innovative technology to empower the pursuit of life’s ambitions in the face of physical[...]
ReWalk Personal Exoskeleton covered as a medically necessary device for an eligible Medicare beneficiary with spinal cord injury MARLBOROUGH, MA, BERLIN, Germany,[...]
R&D Grant from the Israeli Technology Innovation Consortium Enabled the Successful Demonstration of a Working Prototype MARLBOROUGH, Mass. and BERLIN and YOKNEAM[...]
Veterans STAND Act mandates regular evaluations of paralyzed Veterans and proactively identifies clinically-eligible Veterans for expedited procurement of personal exoskeletons. MARLBOROUGH, MA,[...]
MARLBOROUGH, MA, BERLIN, Germany and YOKNEAM ILLIT, Israel, November 6, 2023 – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a[...]
Our mission at Lifeward is to relentlessly drive innovation to change the lives of people with physical limitations or disabilities.
We are committed to delivering groundbreaking solutions that empower individuals to do what they love.